搜索到2709篇“ TAURINE“的相关文章
Taurine as a possible therapy for immunosenescence and inflammaging
2024年
In their recent Science article,Singh et al.identified taurine as an endogenously produced anti-inflammatory,anti-immunosenescence,and anti-aging molecule.The authors also show that restoring taurine to its“youthful”levels prevents inflammation,boosts the immune response,and delays inflammaging/aging.
JoséM.Izquierdo
关键词:TAURINE
Taurine: a promising nutraceutic in the prevention of retinal degeneration
2024年
Taurine is considered a non-essential amino acid because it is synthesized by most mammals.However,dietary intake of taurine may be necessary to achieve the physiological levels required for the development,maintenance,and function of certain tissues.Taurine may be especially important for the retina.The concentration of taurine in the retina is higher than that in any other tissue in the body and taurine deficiency causes retinal oxidative stress,apoptosis,and degeneration of photoreceptors and retinal ganglion cells.Low plasma taurine levels may also underlie retinal degeneration in humans and therefore,taurine administration could exert retinal neuroprotective effects.Taurine has antioxidant,anti-apoptotic,immunomodulatory,and calcium homeostasis-regulatory properties.This review summarizes the role of taurine in retinal health and disease,where it appears that taurine may be a promising nutraceutical.
Diego García-AyusoJohnny Di PierdomenicoAna Martínez-VacasManuel Vidal-SanzSerge PicaudMaría PVillegas-Pérez
关键词:ANTI-INFLAMMATORYANTIOXIDANTNUTRACEUTICALRETINATAURINE
牛磺酸的提取纯化工艺研究进展
2024年
牛磺酸具有显著的生物活性,主要体现为对视网膜的修复作用、对神经系统的保护作用与调节血脂、改善相关酶的活性等。目前牛磺酸的制备方法多样,但逐渐趋向于天然提取法,以降低化学提取带来的不利影响。牛磺酸当前的年消耗量十分庞大,如何提高牛磺酸提取率和安全性,变得十分重要。
杨珍燕香江高平
关键词:生理活性
Emergence of taurine as a therapeutic agent for neurological disorders
2024年
Taurine is a sulfur-containing,semi-essential amino acid that occurs naturally in the body.It alternates between inflammation and oxidative stress-mediated injury in various disease models.As part of its limiting functions,taurine also modulates endoplasmic reticulum stress,Ca^(2+)homeostasis,and neuronal activity at the molecular level.Taurine effectively protects against a number of neurological disorders,including stro ke,epilepsy,cerebral ischemia,memory dysfunction,and spinal cord injury.Although various therapies are available,effective management of these disorders remains a global challenge.Approximately 30 million people are affected worldwide.The design of taurine fo rmation co uld lead to potential drugs/supplements for the health maintenance and treatment of central nervous system disorders.The general neuroprotective effects of taurine and the various possible underlying mechanisms are discussed in this review.This article is a good resource for understanding the general effects of taurine on various diseases.Given the strong evidence for the neuropharmacological efficacy of taurine in various experimental paradigms,it is concluded that this molecule should be considered and further investigated as a potential candidate for neurotherapeutics,with emphasis on mechanism and clinical studies to determine efficacy.
Ashok JangraPriyanka GolaJiten SinghPooja GondSwarnabha GhoshMahesh RachamallaAbhijit DeyDanish IqbalMehnaz KamalPunya SachdevaSaurabh Kumar JhaShreesh OjhaDinesh KumarNiraj Kumar JhaHitesh ChopraShing Cheng Tan
关键词:EPILEPSYNEUROPROTECTIONTAURINE
Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis
2024年
BACKGROUND Liver fibrosis is a compensatory response during the tissue repair process in chronic liver injury,and finally leads to liver cirrhosis or even hepatocellular carcinoma.The pathogenesis of hepatic fibrosis is associated with the progressive accumulation of activated hepatic stellate cells(HSCs),which can transdiffer-entiate into myofibroblasts to produce an excess of the extracellular matrix(ECM).Myofibroblasts are the main source of the excessive ECM responsible for hepatic fibrosis.Therefore,activated hepatic stellate cells(aHSCs),the principal ECM producing cells in the injured liver,are a promising therapeutic target for the treatment of hepatic fibrosis.AIM To explore the effect of taurine on aHSC proliferation and the mechanisms involved.METHODS Human HSCs(LX-2)were randomly divided into five groups:Normal control group,platelet-derived growth factor-BB(PDGF-BB)(20 ng/mL)treated group,mmol/L,respectively)with PDGF-BB(20 ng/mL)treated group.Cell Counting Kit-8 method was performed to evaluate the effect of taurine on the viability of aHSCs.Enzyme-linked immunosorbent assay was used to estimate the effect of taurine on the levels of reactive oxygen species(ROS),malondialdehyde,glutathione,and iron concen-tration.Transmission electron microscopy was applied to observe the effect of taurine on the autophagosomes and ferroptosis features in aHSCs.Quantitative real-time polymerase chain reaction and Western blot analysis were performed to detect the effect of taurine on the expression ofα-SMA,Collagen I,Fibronectin 1,LC3B,ATG5,Beclin 1,PTGS2,SLC7A11,and p62.RESULTS Taurine promoted the death of aHSCs and reduced the deposition of the ECM.Treatment with taurine could alleviate autophagy in HSCs to inhibit their activation,by decreasing autophagosome formation,downregulating LC3B and Beclin 1 protein expression,and upregulating p62 protein expression.Meanwhile,treatment with taurine triggered ferroptosis and ferritinophagy to eliminate aHSCs characterized by iron overload,lipid ROS accumu-lation,glutath
Sen LiQian-Jun RenCan-Hao XieYang CuiLi-Tao XuYi-Dan WangSu LiXing-Qiu LiangBin WenMing-Kun LiangXiao-Fang Zhao
关键词:AUTOPHAGYTAURINE
Mitigating diabetes-related complications:Empowering metformin with cholecalciferol and taurine supplementation in type 2 diabetic rats
2024年
BACKGROUND Type 2 diabetes is one of the most prevalent chronic diseases worldwide,significantly impacting patients'quality of life.Current treatment options like metformin(MET)effectively counteract hyperglycemia but fail to alleviate diabetes-associated complications such as retinopathy,neuropathy,nephropathy,hepatopathy,and cardiovascular diseases.AIM To propose the supplementation of cholecalciferol(CHO)and taurine(TAU)to enhance MET efficacy in controlling diabetes while minimizing the risk of associated complications.METHODS The study involved sixty rats,including ten non-diabetic control rats and fifty experimental rats with type 2 diabetes induced by streptozotocin.The experimental rats were further subdivided into positive control and treatment subgroups.The four treatment groups were randomly allocated to a single MET treatment or MET combined with supplements either CHO,TAU,or both.RESULTS Diabetic rats exhibited elevated levels of glucose,insulin,Homeostasis Model Assessment of Insulin Resistance(HOMA-IR),glycated hemoglobin percentage,lipid markers,aspartate aminotransferase,and malondialdehyde,along with reduced levels of antioxidant enzymes(catalase and superoxide dismutase).The administration of CHO and TAU supplements alongside MET in diabetic rats led to a noticeable recovery of islet mass.The antioxidative,anti-inflammatory,and anti-apoptotic properties of the proposed combination therapy significantly ameliorated the aforementioned abnormalities.CONCLUSION The supplementation of CHO and TAU with MET showed the potential to significantly improve metabolic parameters and protect against diabetic complications through its antioxidative,anti-inflammatory,and antiapoptotic effects.
Mai S AttiaFadwa AymanMohamed S AttiaGalal YahyaMansour H ZahraMagdi Mohamed Ibrahim KhalilAbdel Aziz A Diab
关键词:METFORMINCHOLECALCIFEROLTAURINEANTIOXIDANT
牛磺酸的生理功能及其应用
2024年
牛磺酸来源于蛋氨酸和半胱氨酸代谢,是一种具有强酸的磺酸性两性离子β-氨基酸,含有一个酸性磺酸基、一个碱性氨基和介于两者之间的两个碳,在生理pH范围内表现出较强的水溶性和较差的亲脂性。由于没有羧基,牛磺酸不参与蛋白质合成,属于半必需氨基酸。牛磺酸的理化性质使其成为各种基本生理过程的理想调节剂,具有维持体内稳态、胆汁酸合成、抗氧化应激、抗炎、保护心血管、保护中枢神经系统和参与免疫调节等多种功能。近年来,随着低蛋白日粮的推广和集约化工厂化生产普及,畜禽的抗病能力受到巨大挑战,有必要在日粮中合理添加牛磺酸。因此,文章介绍了牛磺酸在动物生理和动物营养领域的研究进展,旨在为广大畜牧从业人员提供参考。
胡立国胡俊杰魏玉明齐明何智峰赵铎斌
关键词:牛磺酸生理功能
牛磺酸抑制心肌纤维化作用
2024年
目的探讨牛磺酸(Tau)对异丙肾上腺素(Iso)诱导大鼠心肌纤维化(MF)的作用,并阐明其可能的作用机制。方法Wistar大鼠50只,体质量200~250 g,雌、雄各半。随机将Wistar大鼠分为对照组,模型组(Iso组),Tau低(60 mg/(kg·d))、中(120 mg/(kg·d))、高(240 mg/(kg·d))剂量组,每组10只。建立Iso大鼠MF模型,即大鼠背部注射Iso5 mg/(kg·d),连续10 d;对照组注射等体积生理盐水;Tau各剂量组于造模的第2天开始腹腔注射(Tau)给药,1次/d,连续14 d。计算各组大鼠心脏质量指数;HE染色观察心肌组织病理学改变;Masson染色法计算心肌组织胶原百分比;qRT-PCR检测心肌组织中Ⅰ型、Ⅲ型胶原蛋白及结缔组织生长因子(CTGF)mRNA表达。结果Iso组大鼠心脏质量指数显著高于对照组(P<0.05);低、中和高剂量Tau组与模型组比较大鼠心脏质量指数显著降低(P<0.05),且具有浓度依赖性。HE染色结果显示:Iso组大鼠心肌组织中出现典型的MF病理变化;低、中和高剂量Tau组大鼠上述病理变化程度显著改善,且与浓度具有正相关关系。与对照组比较,Iso组大鼠心肌胶原百分比显著高于对照组(P<0.05);与Iso组比较,低、中和高剂量Tau能够显著降低大鼠心肌胶原蛋白百分比(P<0.05)。qRT-PCR结果显示,Iso组大鼠心肌组织中Ⅰ型、Ⅲ型胶原蛋白及CTGF mRNA表达水平显著高于对照组(P<0.01);与Iso组比较,低、中和高剂量Tau能够明显降低Ⅰ型、Ⅲ型胶原蛋白及CTGF mRNA表达水平(P<0.05)。结论Tau可显著降低大鼠心脏质量指数,改善各组大鼠心脏组织病变程度,降低心肌组织中Ⅰ型、Ⅲ型胶原蛋白及CTGF mRNA表达水平,具有抑制大鼠MF的作用。
鞠明乔超峰许熠李枫刘柠刘洋王立英
关键词:牛磺酸CTGF
牛磺酸代谢在抗肿瘤领域的研究进展
2024年
近年来免疫治疗的发展改变了癌症治疗模式,然而,单药免疫治疗有效率低,通过联合化疗、靶向治疗等改变肿瘤微环境能够大大提高其疗效。其中,氨基酸代谢,尤其是牛磺酸代谢可能通过肿瘤微环境的代谢重编程协同增强免疫治疗疗效。该文具体讨论了牛磺酸调控肿瘤微环境和肿瘤细胞代谢的潜在机制,可能为肿瘤免疫治疗提供新的理解。
邢妤佳蔡习强季坤梁俊荣赵晓迪王新
关键词:牛磺酸肿瘤微环境免疫治疗氨基酸代谢
牛磺酸对蟾蜍甾烯在心脏组织分布情况的影响
2024年
目的:考察牛磺酸(Tau)对蟾蜍甾烯在心脏组织分布情况的影响。方法:16只雄性豚鼠随机分为空白组、模型组(8 mg/kg蟾酥)、牛磺酸低剂量组(8 mg/kg蟾酥+150 mg/kg Tau)和牛磺酸高剂量组(8 mg/kg蟾酥+300 mg/kg Tau),给予相应处理后,采用HPLC-ESI-TOF-MS分析不同给药组蟾蜍甾烯类成分在豚鼠心脏中的摄取情况,进一步采用分子对接技术模拟牛磺酸与目前已知心脏疾病相关靶点蛋白SCN5A结合位点。结果:在模型组心脏中检测到Gtl、Arg、Hel、Tel、Btl、Bul、Rbg、Cbg和Cbt共9种蟾蜍甾烯的原型,在肝、肾中检测到部分可能发生羟基化的代谢产物,牛磺酸各剂量组心脏中也测到相关蟾蜍甾烯的原型化合物,但与模型组相比,牛磺酸各剂量组心脏中蟾蜍甾烯的摄入均显著减少;分子对接模拟牛磺酸与SCN5A结合能为-3.7 kcal/mol,牛磺酸可以与受体氨基酸Glu1225、Arg1306、Arg1309之间氢键相连。结论:牛磺酸可延缓蟾蜍甾烯类成分在靶器官心脏中的摄取,从而降低蟾酥的心脏毒性,推测牛磺酸与SCN5A的结合位点可能是Glu1225、Arg1306、Arg1309,这为中药配伍在心脏疾病治疗中的应用提供了实际的实验依据。
于梦蒋洁君马宏跃周婧
关键词:牛磺酸蟾酥配伍

相关作者

袁凌青
作品数:108被引量:219H指数:7
供职机构:中南大学湘雅二医院
研究主题:成骨细胞 糖尿病 骨质疏松 脂联素 人成骨细胞
罗湘杭
作品数:153被引量:633H指数:14
供职机构:中南大学
研究主题:骨密度 成骨细胞 骨质疏松 女性 脂联素
齐永芬
作品数:183被引量:883H指数:15
供职机构:北京大学基础医学院
研究主题:肾上腺髓质素 血管钙化 INTERMEDIN 血管平滑肌细胞 受体活性修饰蛋白
唐朝枢
作品数:1,478被引量:7,586H指数:40
供职机构:北京大学基础医学院生理学与病理生理学系
研究主题:内皮素 肾上腺髓质素 高血压 硫化氢 牛磺酸
廖二元
作品数:512被引量:3,783H指数:24
供职机构:中南大学湘雅二医院
研究主题:骨密度 骨质疏松 成骨细胞 骨质疏松症 女性